News
Atlassian Named a Leader in the 2022 Gartner® Magic Quadrant™ for IT Service Management Platforms
Atlassian Corporation (NASDAQ: TEAM), a leading provider of team collaboration and productivity software, has been named a Leader in the 2022 Gartner® Magic Quadrant™ for IT Service Management
Nordson Corporation Completes Acquisition of CyberOptics Corporation
Nordson Corporation (Nasdaq: NDSN) has completed the acquisition of CyberOptics Corporation, a leading global developer and manufacturer of high-precision 3D optical sensing technology solutions
Granite Furthers Relationship with DHS and USCG Through Strategic Pacific Northwest Win
Granite (NYSE:GVA) has been awarded an approximately $30 million dollar construction contract for various Design-Build improvements at East Tongue Point near Astoria, Oregon. The project will be
Douglas Emmett Releases Third Quarter 2022 Earnings Results
Douglas Emmett, Inc. (NYSE: DEI), a real estate investment trust (REIT), has released its Third Quarter 2022 Earnings Results and Operating Information package by posting it to the investor
The L.S. Starrett Company Announces Fiscal 2023 First Quarter Results
The L.S. Starrett Company (NYSE: SCX) (“Starrett” or “the Company”) a global innovator, manufacturer and marketer of precision measuring tools, cutting tools and equipment, and high-end metrology
Willdan Awarded $11 Million Contract with Azusa Unified School District
Willdan Group, Inc. (NASDAQ: WLDN) announced today that it has been selected by Azusa Unified School District to perform $11 million in energy conservation and infrastructure improvement projects
Victory Capital Reports Strong Third-Quarter Earnings and Positive Net Long-Term Flows for Year-to-Date Period
Victory Capital Holdings, Inc. (NASDAQ: VCTR) (“Victory Capital” or “the Company”) today reported financial results for the quarter ended September 30, 2022.
“Our business continued to perform
Ventas Reports 2022 Third Quarter Results
Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today reported results for the third quarter ended September 30, 2022.
Third Quarter 2022 Highlights
-
Net Income Attributable to Common
Fuel Tech Awarded Air Pollution Control Orders Totaling $2.7 Million
Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control and water treatment in utility and
Puma Biotechnology Reports Third Quarter 2022 Financial Results
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced financial results for the third quarter ended September 30, 2022. Unless otherwise stated, all comparisons are for
Viad Corp Reports Results for the 2022 Third Quarter
Viad Corp (NYSE: VVI), a leading provider of experiential leisure travel and live events and marketing experiences, today reported net income attributable to Viad of $40.1 million for the 2022
Willdan Group Reports Third Quarter 2022 Results
Willdan Group, Inc. (“Willdan”) (Nasdaq: WLDN), a provider of professional, technical and consulting services, today reported financial results for its third quarter ended September 30, 2022.
BlackRock Capital Investment Corporation Reports Financial Results for the Quarter Ended September 30, 2022, Declares Quarterly Cash Dividend of $0.10 per Share
BlackRock Capital Investment Corporation (NASDAQ:BKCC) (“BCIC” or the “Company,” “we,” “us” or “our”) announced today that its Board of Directors declared a quarterly dividend of $0.10 per share
Cognex Reports Third Quarter 2022 Results
Cognex Corporation (NASDAQ: CGNX) today reported financial results for the third quarter of 2022. Table 1 below shows selected financial data for Q3-22 compared with Q3-21 and Q2-22, and for the
Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2022 Financial Results
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today reported recent business highlights and third quarter 2022 financial results.
“This has been a year marked by
Upland Software Reports Third Quarter 2022 Financial Results
Upland Software, Inc. (Nasdaq: UPLD), a leader in cloud-based tools for digital transformation, today announced financial and operating results for the third quarter 2022 and issued guidance for
Polaris Declares Regular Cash Dividend
Polaris Inc. (NYSE: PII) announced today that its Board of Directors has declared a regular quarterly cash dividend of $0.64 per share payable on December 15, 2022 to shareholders of record at the
Skyworks Reports Q4 and Full Year FY22 Results
Skyworks Solutions, Inc. (Nasdaq: SWKS), an innovator of high-performance analog and mixed signal semiconductors connecting people, places and things, today reported fourth fiscal quarter and
VICI Properties Inc. Announces Public Offering of Common Stock
VICI Properties Inc. (NYSE: VICI) (“VICI Properties” or the “Company”), an experiential asset real estate investment trust, today announced it has commenced an underwritten public offering of
Atlassian Announces First Quarter Fiscal Year 2023 Results
Atlassian Corporation (NASDAQ: TEAM), a leading provider of team collaboration and productivity software, today announced financial results for its first quarter of fiscal year 2023 ended September
Cognex Increases Quarterly Cash Dividend
Cognex Corporation (NASDAQ: CGNX) today announced that the company's Board of Directors declared a quarterly cash dividend of $0.07 per share, payable on December 2, 2022 to all shareholders of
Connection (CNXN) Reports Third Quarter 2022 Results
Connection (PC Connection, Inc.; NASDAQ: CNXN), a leading information technology solutions provider to business, government, healthcare and education markets, today announced results for the third
Acadia Healthcare to Participate in Credit Suisse 31st Annual Healthcare Conference
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in the Credit Suisse 31st Annual Healthcare Conference, November 7 - 10, 2022, at Terranea Resort in
Pfizer’s Elranatamab Granted FDA Breakthrough Therapy Designation for Relapsed or Refractory Multiple Myeloma
Pfizer Inc. (NYSE:PFE) today announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for the